ResearcherUnited Arab Emirates UniversityNo recent work listed

J. Al Shemaili

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5024021671. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 1 paper

Papers 2

Pharmacokinetics in Mouse and Comparative Effects of Frondosides in Pancreatic Cancer. Co-author DOI 10.3390/md14060115 ↗
Frondoside A enhances the antiproliferative effects of gemcitabine in pancreatic cancer. Co-author DOI 10.1016/j.ejca.2014.01.002 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Thomas Edward Adrian · 2 shared papers, 2014–2016 · strength 0.10
- Paper Pharmacokinetics in Mouse and Comparative Effects of Frondosides in Pancreatic Cancer. DOI 10.3390/md14060115 ↗
- Paper Frondoside A enhances the antiproliferative effects of gemcitabine in pancreatic cancer. DOI 10.1016/j.ejca.2014.01.002 ↗
Robert Alan Newman · 1 shared paper, 2016 · strength 0.06
- Paper Pharmacokinetics in Mouse and Comparative Effects of Frondosides in Pancreatic Cancer. DOI 10.3390/md14060115 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.